EXACT SCIENCES CORP (EXAS) Receivables - Net (2014 - 2025)

Exact Sciences (EXAS) has reported Receivables - Net for 12 consecutive years, with $298.7 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Receivables - Net rose 19.96% year-over-year to $298.7 million in Q4 2025; TTM through Dec 2025 was $298.7 million, a 19.96% increase from a year earlier, with the FY2025 full-year figure at $298.7 million, up 19.96% from the prior year.
• Receivables - Net was $298.7 million for Q4 2025 at Exact Sciences, down from $306.1 million in the prior quarter.
• Over five years, Receivables - Net peaked at $353.3 million in Q2 2025 and troughed at $158.0 million in Q4 2022.
• A 5-year average of $235.5 million and a median of $233.6 million in 2021 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net soared 82.89% in 2021 and dropped 27.05% in 2022, its largest moves.
• Over 5 years, Receivables - Net stood at $216.6 million in 2021, then fell by 27.05% to $158.0 million in 2022, then gained by 28.84% to $203.6 million in 2023, then climbed by 22.27% to $249.0 million in 2024, then advanced by 19.96% to $298.7 million in 2025.
• The last three Receivables - Net figures came in at $298.7 million (Q4 2025), $306.1 million (Q3 2025), and $353.3 million (Q2 2025), per Business Quant data.